These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 14668942)

  • 1. Molecule of the month. Cinacalcet hydrochloride.
    Drug News Perspect; 2003 Sep; 16(7):470. PubMed ID: 14668942
    [No Abstract]   [Full Text] [Related]  

  • 2. Cinacalcet hydrochloride (Amgen).
    Iqbal J; Zaidi M; Schneider AE
    IDrugs; 2003 Jun; 6(6):587-92. PubMed ID: 12811682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium, calcimimetics and clinical outcomes.
    Block G
    Clin J Am Soc Nephrol; 2006 Mar; 1(2):170-1. PubMed ID: 17699205
    [No Abstract]   [Full Text] [Related]  

  • 4. Persistent and symptomatic post-transplant hyperparathyroidism: a dramatic response to cinacalcet.
    Leonard N; Brown JH
    Nephrol Dial Transplant; 2006 Jun; 21(6):1736. PubMed ID: 16364985
    [No Abstract]   [Full Text] [Related]  

  • 5. Implementation of 'K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease' after the introduction of cinacalcet in a population of patients on chronic haemodialysis.
    Arenas MD; Alvarez-Ude F; Gil MT; Moledous A; Malek T; Nuñez C; Devesa R; Carretón MA; Soriano A
    Nephrol Dial Transplant; 2007 Jun; 22(6):1639-44. PubMed ID: 17277339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cinacalcet increases calcium excretion in hypercalcemic hyperparathyroidism after kidney transplantation.
    Borchhardt KA; Heinzl H; Mayerwöger E; Hörl WH; Haas M; Sunder-Plassmann G
    Transplantation; 2008 Oct; 86(7):919-24. PubMed ID: 18852656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cinacalcet on renal electrolyte handling and systemic arterial blood pressure in kidney transplant patients with persistent hyperparathyroidism.
    Zitt E; Woess E; Mayer G; Lhotta K
    Transplantation; 2011 Oct; 92(8):883-9. PubMed ID: 21876476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cinacalcet cessation in renal transplant recipients with persistent hyperparathyroidism.
    Kruse AE; Eisenberger U; Frey FJ; Mohaupt MG
    Nephrol Dial Transplant; 2007 Aug; 22(8):2362-5. PubMed ID: 17510094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial differences in response to cinacalcet as a treatment for uremic hyperparathyroidism.
    Gupta A; Heslin KC
    Kidney Int; 2006 Mar; 69(6):1094. PubMed ID: 16528262
    [No Abstract]   [Full Text] [Related]  

  • 10. Parathyroidectomy versus cinacalcet hydrochloride-based medical therapy in the management of hyperparathyroidism in ESRD: a cost utility analysis.
    Narayan R; Perkins RM; Berbano EP; Yuan CM; Neff RT; Sawyers ES; Yeo FE; Vidal-Trecan GM; Abbott KC
    Am J Kidney Dis; 2007 Jun; 49(6):801-13. PubMed ID: 17533023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphatemic effect of cinacalcet in kidney transplant recipients with persistent hyperparathyroidism.
    Serra AL; Wuhrmann C; Wüthrich RP
    Am J Kidney Dis; 2008 Dec; 52(6):1151-7. PubMed ID: 18950915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normalization of lithium-induced hypercalcemia and hyperparathyroidism with cinacalcet hydrochloride.
    Sloand JA; Shelly MA
    Am J Kidney Dis; 2006 Nov; 48(5):832-7. PubMed ID: 17060004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hyperparathyroidism with cinacalcet in kidney transplant recipients.
    Borstnar S; Erzen B; Gmeiner Stopar T; Kocjan T; Arnol M; Kandus A; Kovac D
    Transplant Proc; 2010 Dec; 42(10):4078-82. PubMed ID: 21168632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of reversed whole PTH/intact PTH ratio and reduction in parathyroid gland vascularity during cinacalcet therapy for severe hyperparathyroidism in a uraemic patient.
    Komaba H; Shin J; Fukagawa M
    Nephrol Dial Transplant; 2010 Feb; 25(2):638-41. PubMed ID: 19892751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of cinacalcet on bone remodeling and renal function in transplant patients with persistent hyperparathyroidism.
    Schwarz A; Merkel S; Leitolf H; Haller H
    Transplantation; 2011 Mar; 91(5):560-5. PubMed ID: 21192318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel dose regimen of cinacalcet in the treatment of severe hyperparathyroidism in hemodialysis patients.
    Al-Hilali N; Hussain N; Kawy YA; Al-Azmi M
    Saudi J Kidney Dis Transpl; 2011 May; 22(3):448-55. PubMed ID: 21566299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cinacalcet: An oral calcimimetic agent for the management of hyperparathyroidism.
    Dong BJ
    Clin Ther; 2005 Nov; 27(11):1725-51. PubMed ID: 16368445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic failure of cinacalcet in a renal transplant patient presenting hyperparathyroidism with severe hypercalcaemia.
    Boulanger H; Haymann JP; Fouqueray B; Mansouri R; Metivier F; Sarfati E; Glotz D
    Nephrol Dial Transplant; 2005 Dec; 20(12):2865. PubMed ID: 16115841
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal function in patients treated with cinacalcet for persistent hyperparathyroidism after kidney transplantation.
    Henschkowski J; Bischoff-Ferrari HA; Wüthrich RP; Serra AL
    Kidney Blood Press Res; 2011; 34(2):97-103. PubMed ID: 21273790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cinacalcet on bone mineral density in patients with secondary hyperparathyroidism.
    Lien YH; Silva AL; Whittman D
    Nephrol Dial Transplant; 2005 Jun; 20(6):1232-7. PubMed ID: 15840675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.